HomeInsightsPE

Bal Pharma Ltd PE Ratio

Bal Pharma Ltd PE Ratio

stocks purchased

₹ 0.0 Cr

Volume transacted

stocks purchased

0.0 K

stocks traded

Last Updated time: 14 Oct 11:16 AM

Image

Bal Pharma Ltd

NSE: BALPHARMA

PE

27

Last updated: 14 Oct 11:16 AM

Key Highlights

  • The P/E Ratio of Bal Pharma Ltd is 27 as of 14 Oct 11:16 AM.
  • The P/E Ratio of Bal Pharma Ltd changed from 26.4 on March 2019 to 19.5 on March 2024 . This represents a CAGR of -4.92% over 6 years. .
  • The Latest Trading Price of Bal Pharma Ltd is ₹ 128.4 as of 14 Oct 11:04.
  • The PE Ratio of Pharmaceuticals Industry has changed from 28.2 to 27.1 in 5 years. This represents a CAGR of -0.79%.
  • The PE Ratio of Automobile industry is 20.2. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.3. The PE Ratio of Pharmaceuticals industry is 40.0. The PE Ratio of Retail industry is 158.1. The PE Ratio of Textiles industry is 37.6. In 2024.

Historical P/E Ratio of Bal Pharma Ltd

No data available

Company Fundamentals for Bal Pharma Ltd

No data available

Image

Bal Pharma Ltd

NSE: BALPHARMA

PRICE

128.4

0.05 (0.04%)

stock direction

Last updated: 14 Oct 11:04

Market price Over Time

1M

1Y

3Y

5Y

Monitoring Bal Pharma Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPriceleft
11 Oct 2024128.35
10 Oct 2024133.65
09 Oct 2024134
08 Oct 2024132.95
07 Oct 2024126.65
04 Oct 2024132
03 Oct 2024134.3
01 Oct 2024138.5
30 Sep 2024135.8
27 Sep 2024134.45

SWOT Analysis Of Bal Pharma Ltd

Strength

2

S

Weakness

2

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Bal Pharma Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Bal Pharma Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of P/E Ratio

Company NamePEMarket Cap (INR Cr.)
Bal Pharma Ltd27204
Sun Pharmaceuticals Industries Ltd434,56,342
Divis Laboratories Ltd971,63,028
Cipla Ltd291,28,827
Torrent Pharmaceuticals Ltd701,18,373
Mankind Pharma Ltd571,11,956

Key Valuation Metric of Bal Pharma Ltd

No data available

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Bal Pharma Ltd

No data available

* All values are in crore

Historical Revenue of Bal Pharma Ltd

No data available

* All values are in crore

Historical EBITDA of Bal Pharma Ltd

No data available

* All values are in crore

Historical Net Profit of Bal Pharma Ltd

No data available

* All values are in crore

Historical Dividend Payout of Bal Pharma Ltd

No data available

* All values are in %

About Bal Pharma Ltd

  • Bal Pharma Ltd (BPL), a member of the Mcro Laboratories Group, was incorporated as a private limited company in May '87.
  • In Mar.'90, BPL took over a pharmaceutical products manufacturing unit located in Bangalore through the Karnataka State Finance Corporation for a consideration of Rs 25.18 lac following which, BPL commenced manufacturing formulations. BPL manufactures and markets pharmaceutical formulations -- paracetamol, aluminium hydroxide, povidone iodine, alprazolam, gliclazide, griseofulvin, lactobacillus, rifampicin, piroxicam amoxycillin, etc.
  • The company promotes its products through the common sales force of the group but proposes to induct its own soon.
  • It came out with a public issue in Feb.'95 for manufacture of bulk drugs and expansion of pharmaceutical formulations. During 1997-98, the formalities of takeover of the unit from Lakme Limited have been completed and effective from 23rd July, 1997 the unit has become a division of Bal Pharma Limited.

Bal Pharma Ltd News Hub

News

Bal Pharma to convene board meeting

Bal Pharma will hold a meeting of the Board of Directors of the Company on 9 September 202...

Read more

31 Aug 202410:27

News

Bal Pharma schedules AGM

Bal Pharma announced that the Annual General Meeting (AGM) of the company will be held on ...

Read more

16 Aug 202411:19

News

Bal Pharma schedules board meeting

Bal Pharma will hold a meeting of the Board of Directors of the Company on 12 August 2024....

Read more

26 Jul 202416:28

News

Board of Bal Pharma recommends final dividend

Bal Pharma announced that the Board of Directors of the Company at its meeting held on 28 ...

Read more

29 May 202409:43

News

Bal Pharma Ltd leads gainers in 'B' group

Amines & Plasticizers Ltd, Jet Freight Logistics Ltd, Arrow Greentech Ltd and Emkay Global...

Read more

29 May 202412:15

News

Bal Pharma hits the roof after Q4 PAT surges to Rs 5 cr

Revenue from operations jumped 14.76% YoY to Rs 94.62 crore in Q4 FY24. Profit before tax ...

Read more

29 May 202414:47

Product Composition

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

FAQs for PE of Bal Pharma Ltd

What is the current PE Ratio of Bal Pharma Ltd?

The Current PE Ratio of Bal Pharma Ltd is 27.02 as on 14 Oct 2024.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 40.0 as on 14 Oct 2024.

What was the PE Ratio of Bal Pharma Ltd last year?

The PE Ratio of Bal Pharma Ltd was 40.81 last year, now the PE ratio is 27.02, showing a year-on-year growth of -33.8%.

What does the PE Ratio of Bal Pharma Ltd indicate about its stock?

The PE Ratio of Bal Pharma Ltd is 27.02. This ratio indicates that investors are willing to pay 27.02 times the earnings per share for each share of Bal Pharma Ltd.

What is the PE Ratio Growth of Bal Pharma Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Bal Pharma Ltd grew by -33.8% whereas, the EPS ratio grew by -95.7.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*